Defendant Name: Allergan, Inc.

Defendant Type: Subsidiary of Public Company

Document Reference: 2017-16

Document Details

Legal Case Name In the Matter of Allergan, Inc.
Document Name Allergan Paying $15 Million Penalty for Disclosure Failures During Merger Talks
Document Date 17-Jan-2017
Document Format Administrative Proceeding
File Number 3-17790
Allegation Type Issuer Reporting and Disclosure
Document Summary On January 17, 2017 the SEC announced in a press release that Allergan Inc. "has agreed to admit securities law violations and pay a $15 million penalty for disclosure failures in the wake of a hostile takeover bid." According to the SEC: "Allergan failed to disclose in a timely manner its negotiations with potentially friendlier merger partners in the months following a tender offer from Valeant Pharmaceuticals International and co-bidders in June 2014."

Disgorgement & Penalty Information

Resolutions
Cease and Desist Order

Related Documents:

34-79814 17-Jan-2017 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On January 17, 2017 the SEC instituted a settled order against Allergan, Inc. According to the SEC: Allergan failed "to comply with the disclosure requirements concerning merger and acquisition negotiations with third parties that it conducted in response to a tender offer."